Kither Biotech Doses First Patients in KIT2014 COPD Trial
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
EASD 2026
Advertisement
Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
Revvity Launches CE-IVDR T1D Early Detection Solution
WALTHAM, Mass. — September 24, 2026 Revvity, Inc. announced the launch of the GSP® T1D 3plex kit, a fully...
MitoRx to Present MTRX31 Obesity Data at EASD 2026
HARWELL, Oxford, UK — September 17, 2026 MitoRx Therapeutics announced that new data for its lead mitochondrial-targeted small molecule...
Kura Oncology launches Caspian Therapeutics with $50M financing
SAN DIEGO — September 9, 2026 Kura Oncology, Inc. announced the launch of Caspian Therapeutics, Inc., a separately financed...
Advertisements
Ribo Unveils Positive Phase 2a Data for Vortosiran in CAD
SHANGHAI, China and MÖLNDAL, Sweden, July 22, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...
Ascletis Reports Superior ASC36_35 Weight Loss Data at EASD 2026
HONG KONG, July 23, 2026 Ascletis Pharma Inc. has announced that new preclinical data for its investigational obesity therapy...
Century Therapeutics Showcases CNTY-813 at EASD
PHILADELPHIA, July 9, 2026 Century Therapeutics announced that its CNTY-813 preclinical research has been selected for oral presentations at...
Sana Biotechnology to Present UP421 Clinical Data at EASD 2026
SEATTLE, July 1, 2026 Sana Biotechnology, Inc. announced that new clinical data from a first-in-human investigator-sponsored study evaluating UP421,...
Advertisement
